| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.017 | 0.9 |